Rep. Robert Bresnahan, Jr. Purchases Shares of Waters Co. (NYSE:WAT)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Waters Co. (NYSE:WAT). In a filing disclosed on March 27th, the Representative disclosed that they had bought between $1,001 and $15,000 in Waters stock on February 25th. The trade occurred in the Representative’s “JP MORGAN BROKERAGE ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Intuit (NASDAQ:INTU) on 3/7/2025.
• Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/6/2025.
• Purchased $1,001 – $15,000 in shares of SEA (NYSE:SE) on 3/5/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Twilio (NYSE:TWLO) on 3/4/2025.
• Sold $15,001 – $50,000 in shares of Alibaba Group (NYSE:BABA) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Zoom Video Communications (NASDAQ:ZM) on 3/4/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 3/3/2025.
• Purchased $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 3/3/2025.

Waters Stock Performance

Shares of Waters stock opened at $361.61 on Friday. Waters Co. has a 52 week low of $279.24 and a 52 week high of $423.56. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. The stock has a market capitalization of $21.48 billion, a price-to-earnings ratio of 33.76, a PEG ratio of 3.79 and a beta of 1.00. The firm has a fifty day moving average of $387.41 and a two-hundred day moving average of $372.60.

Waters (NYSE:WAT) last issued its earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. As a group, equities research analysts predict that Waters Co. will post 12.86 EPS for the current year.

Hedge Funds Weigh In On Waters

A number of institutional investors have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd bought a new position in shares of Waters in the 4th quarter valued at about $28,000. Bank of Jackson Hole Trust acquired a new stake in Waters in the 4th quarter valued at about $34,000. Fortitude Family Office LLC grew its holdings in Waters by 235.7% during the fourth quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 66 shares during the period. Steward Partners Investment Advisory LLC increased its position in Waters by 129.3% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 53 shares during the last quarter. Finally, Murphy & Mullick Capital Management Corp bought a new stake in Waters in the fourth quarter valued at approximately $42,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

WAT has been the subject of several research analyst reports. Wells Fargo & Company boosted their price objective on Waters from $415.00 to $420.00 and gave the company an “overweight” rating in a research report on Thursday, February 13th. StockNews.com cut shares of Waters from a “buy” rating to a “hold” rating in a report on Tuesday, February 25th. UBS Group increased their price objective on shares of Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a research report on Thursday, February 13th. Barclays raised shares of Waters from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $360.00 to $415.00 in a research report on Monday, February 10th. Finally, Scotiabank upgraded Waters from a “sector perform” rating to a “sector outperform” rating and increased their target price for the stock from $430.00 to $450.00 in a report on Thursday, February 13th. Ten investment analysts have rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $397.40.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.